Abstract:INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is recognized as the most prevalent liver abnormality in the United States, with nearly 10% of the population demonstrating some form of the disease. Incidence can reach as high as 70% in patients who are obese and/or have type II diabetes [1]. Many rodent models have been developed to study NAFLD, which are induced by both diet and genetic manipulation [2]. The methionine choline deficient (MCD) model has been used to develop NAFLD, with onset of disease readily visible after 2 weeks on the diet. Changes in reduction and oxidation (redox) have been implicated in the development of this disease as well as its response to therapy [3]. Methods to detect redox changes in these animal models non-invasively are limited. Recent development of hyperpolarized (HP) [1-C] dehydroascorbate (DHA), using the dissolution dynamic nuclear polarization (DNP) technique, provides a new redox sensor to address NAFLD and its treatment. HP DHA is readily transported into the cell and reduced to Vitamin C (VitC) in vivo. The aim of this study was to use HP [1-C] DHA to image redox changes in a standard model of NAFLD and correlate these findings with standard H imaging and histopathology. METHODS: Prior to and post diet, high-resolution T2 and fat-water imaging was conducted at 14T using a Varian WB600 micro-imager and 40mm H millipede coil (Varian Instruments, Palo Alto, CA). Lipid percentage maps were calculated from fat and water images acquired using a conventional spin-echo sequence using the Dixon method [4]. 350μL of hyperpolarized DHA was injected each mouse (n=4) at baseline and 2 weeks of MCD diet using a Hypersense (Oxford Instruments), as previously described [5]. C MRSI data was acquired using an EPSI readout, variable flip angle scheme, matrix size 16 x 8 x 8 and final voxel resolution of 6mm isotropic on a 3T GE MRI (GE Healthcare, Waukesha, WI) equipped with a multinuclear package and dual-tuned H-C imaging coil. MR data was processed offline using custom software written in IDL 8 (ITT Visual Information Solutions, CO, USA) and Matlab 2009b (MathWorks, MA, USA). Ratios of HP DHA and VitC were calculated from the peak integrals in 3D MRSI data. Mice were then sacrificed and liver tissue was sectioned for staining with hematoxylin and eosin (H&E, structure) and Oil Red (lipid presence). Livers of normal mice were used for histologic comparison.

Lipidomics Workflow for Analyzing Lipid Profiles Using Multiple Reaction Monitoring (MRM) in Liver Homogenate of Mice with Non-alcoholic Steatohepatitis (NASH)

Proteomic Analysis of Liver Mitochondria from Rats with Nonalcoholic Steatohepatitis

A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.

LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice

Coordinated Changes of Gut Microbiome and Lipidome Differentiates Nonalcoholic Steatohepatitis (NASH) from Isolated Steatosis.

Oxidative Stress Linked Organ Lipid Hydroperoxidation and Dysregulation in Mouse Model of Nonalcoholic Steatohepatitis: Revealed by Lipidomic Profiling of Liver and Kidney

Liquid Extraction Surface Analysis Mass Spectrometry Method for Identifying the Presence and Severity of Nonalcoholic Fatty Liver Disease

Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis

Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease

High-coverage Quantitative Liver Metabolomics Using Perfused and Non-Perfused Liver Tissues.

Integration of Metabolomics, Lipidomics, and Proteomics Reveals the Metabolic Characterization of Nonalcoholic Steatohepatitis.

Sequential Ultrasound Molecular Imaging for Noninvasive Identification and Assessment of Non-Alcoholic Steatohepatitis in Mouse Models

Protein Profiling and Functional Analysis of Liver Mitochondria from Rats with Nonalcoholic Steatohepatitis

Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS

Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice

Analysis of Metabolic Changes in Endogenous Metabolites and Diagnostic Biomarkers for Various Diseases Using Liquid Chromatography and Mass Spectrometry

Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH

The metabolomics analysis of liver and serum in different phenotypes of non-alcoholic fatty liver disease

Discrimination of lipid composition and cellular localization in human liver tissues by stimulated Raman scattering microscopy

Molecular Imaging of Non-Alcoholic Fatty Liver Disease using an Endogenous Hyperpolarized Redox Sensor